ISRCTN16114765进行中（未招募）Unknown
A prospective feasibility study to assess ex vivo real-time analysis of detrusor muscle status at time of primary transurethral resection of bladder tumour (TURBT) using fluorescence confocal microscopy
适应症
试验速览
- 阶段
- Unknown
- 状态
- 进行中（未招募）
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •Patients undergoing initial or first transurethral resection of bladder tumour (TURBT) for suspected bladder cancer.
排除标准
- •1. Radiological or clinical suspicion of muscle-invasive bladder cancer (cT2-T4)
- •2. Prior diagnosis of NMIBC or MIBC on prior resection
- •3. Patients who do not consent for ex vivo tissue research through Imperial College Healthcare Tissue Bank (ICHTB)
- •4. Patients enrolled in concurrent clinical trials requiring ex vivo tissue for research
研究者
相似试验
已完成
不适用
Prospective study for evaluating feasibily and utility of comprehensive genomic profiling test before initial systemic treatment in advanced malignant solid tumor patientsAdvanced or recurrent solid cancer (non-small cell lung cancer, breast cancer, gastric cancer, colorectal cancer, pancreatic cancer, or biliary tract cancer)JPRN-UMIN000040743ational Cancer Center200
已完成
不适用
A prospective clinical study to evaluate the feasibility and safeness of the chemotherapy with weekly paclitaxel administration in cases with anaplastic thyroid cancerJPRN-UMIN000008574Anaplastic Thyroid Carcinoma Consortium Japan50
已完成
不适用
A clinical feasibility study to evaluate the effectiveness and safety of VivescOs™ as bone graft for reconstruction of intra-oral osseous defectsISRCTN92152389IsoTis NV (The Netherlands)10
尚未招募
2 期
A Study Where twice weekly radiotherapy will be given internally during external beam radiotherapy treatment to see the feasibility toxicity and efficacy in locally advanced cervical cancerCTRI/2019/10/021486RADIOTHERAPY DEPARTMENT SSKM HOSPITA
尚未招募
不适用
An exploratory study to evaluate in vivo, ex vivo and clinical hypersensitivity reactions after first-time treatment with complement-reactogenic infusionsNL-OMON56981Centre for Human Drug Research60